Sernia classification of sln
Serna classification sentinel lymph node SLN
"Sernia classification" lymph node
Starz classification sentinel lymph node melanoma SLN metastasis grading
Starz S-classification sentinel lymph node criteria S0 S1 S2 S3
| Stage | Criteria | Pathological Description |
|---|---|---|
| S0 | n = 0 | No detectable tumor cells — negative SLN |
| S1 | 1 ≤ n ≤ 2 AND d ≤ 0.3 mm | Peripheral/subcapsular involvement only — localized peripheral tumor cell deposits |
| S2 | n > 2 AND 0.3 < d ≤ 1 mm | Extended or multifocal peripheral involvement — more extended peripheral metastases |
| S3 | d > 1 mm | Deep metastatic infiltration — invasion deeper than 1 mm below the capsular level |
| Stage | NSLN Positivity at CLND | Implication |
|---|---|---|
| S1 | ~0% | CLND may be safely omitted |
| S2 | ~15–40% | Intermediate risk; individualize decision |
| S3 | ~60% | High risk; CLND strongly recommended |
Cernea classification
Cernea classification external branch superior laryngeal nerve thyroidectomy
| Type | Criteria | Risk of Injury |
|---|---|---|
| Type 1 | EBSLN crosses the STA ≥1 cm above the superior thyroid pole | Low — nerve is well above the operative field |
| Type 2a | EBSLN crosses the STA <1 cm above the superior thyroid pole | Moderate — near the superior pedicle; careful dissection required |
| Type 2b | EBSLN crosses the STA below the upper border of the superior pole (under cover of the pole) | High — most at-risk type; can easily be included in a ligature |

| Type | Small goiters | Large goiters |
|---|---|---|
| Type 1 | ~68% | ~23% |
| Type 2a | ~11% | ~15% |
| Type 2b | ~14% | ~54% |
Large goiters significantly shift the nerve downward, dramatically increasing the proportion of Type 2b — the highest-risk variant.